1. Home
  2. PRAX vs ANF Comparison

PRAX vs ANF Comparison

Compare PRAX & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • ANF
  • Stock Information
  • Founded
  • PRAX 2015
  • ANF 1892
  • Country
  • PRAX United States
  • ANF United States
  • Employees
  • PRAX N/A
  • ANF N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • ANF Clothing/Shoe/Accessory Stores
  • Sector
  • PRAX Health Care
  • ANF Consumer Discretionary
  • Exchange
  • PRAX Nasdaq
  • ANF Nasdaq
  • Market Cap
  • PRAX 4.0B
  • ANF 3.8B
  • IPO Year
  • PRAX 2020
  • ANF 1996
  • Fundamental
  • Price
  • PRAX $179.18
  • ANF $71.39
  • Analyst Decision
  • PRAX Strong Buy
  • ANF Buy
  • Analyst Count
  • PRAX 12
  • ANF 10
  • Target Price
  • PRAX $212.42
  • ANF $107.10
  • AVG Volume (30 Days)
  • PRAX 978.5K
  • ANF 1.6M
  • Earning Date
  • PRAX 11-05-2025
  • ANF 11-25-2025
  • Dividend Yield
  • PRAX N/A
  • ANF N/A
  • EPS Growth
  • PRAX N/A
  • ANF 13.04
  • EPS
  • PRAX N/A
  • ANF 10.58
  • Revenue
  • PRAX $7,463,000.00
  • ANF $5,099,754,000.00
  • Revenue This Year
  • PRAX N/A
  • ANF $7.57
  • Revenue Next Year
  • PRAX $44.43
  • ANF $3.98
  • P/E Ratio
  • PRAX N/A
  • ANF $6.77
  • Revenue Growth
  • PRAX 364.98
  • ANF 9.34
  • 52 Week Low
  • PRAX $26.70
  • ANF $65.40
  • 52 Week High
  • PRAX $206.71
  • ANF $164.80
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 62.04
  • ANF 43.70
  • Support Level
  • PRAX $159.74
  • ANF $69.64
  • Resistance Level
  • PRAX $188.53
  • ANF $73.14
  • Average True Range (ATR)
  • PRAX 13.41
  • ANF 2.66
  • MACD
  • PRAX -5.00
  • ANF 0.65
  • Stochastic Oscillator
  • PRAX 47.30
  • ANF 47.81

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.

Share on Social Networks: